M&A Deal Summary |
|
|---|---|
| Date | 2016-06-02 |
| Target | MBiotech |
| Sector | Marketing |
| Buyer(s) | Integrated DNA Technologies |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Medical Products |
Integrated DNA Technologies, Inc. is a manufacturer of custom nucleic acids (i.e. building blocks of DNA and RNA) and assists researchers in advancing genomics technology, including synthetic biology and Next-Generation Sequencing. The company serves more than 80,000 customers across a diverse set of end markets including academic research, biotechnology, clinical diagnostics and pharmaceuticals.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 7 |
| Sector: Marketing M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 3 |
| Country: South Korea M&A | 1 of 1 |
| Year: 2016 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-12-01 |
AITBIOTECH - Oligonucleotide Synthesis Business
Singapore, Singapore AITBIOTECH - Oligonucleotide Synthesis Business engages in the supply of products and services to scientists involved in Life Science Research, Molecular Diagnostic and Therapeutic development and commercialisation. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-06-10 |
ValueGene
San Diego, California, United States ValueGene, Inc. is an oligonucleotide synthesis services company offers custom DNA and RNA oligonucleotide synthesis products, including PAGE and HPLC purification and modification services. |
Buy | - |
